Rockefeller University
New York, New York, United States
Purpose
to fund a study testing the hypothesis that broadly neutralizing antibodies against HIV-1 produced by gene editing can protect against infection
Division
Global Health
Date
August 2019
Region Served
GLOBAL
Committed amount
$2,838,049
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
48
Grantee location
New York, New York, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.